share_log

Eiger BioPharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%), etc.

Eiger BioPharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%), etc.

Eiger BioPharmaceuticals | SC 13D:超過5%持股股東披露文件-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%)等
美股sec公告 ·  2023/10/20 16:29
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息